FDA
-
-
-
-
-
-
-
Pfizer executive says China now leads Europe in drug innovation
-
-
-
-
-
-
-
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
-
-
-
-
-
-
-
FDA Commissioner Marty Makary to step down - Politico
-
-
-
-
-
-
-
FDA approves first PROTAC therapy VEPPANU for breast cancer
-
-
-
-
-
-
-
AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities
-
-
-
-
-
-
-
FDA approves Pfizer's BRAFTOVI for colorectal cancer treatment
-
-
-
-
-
-
-
FDA grants priority review for Pfizer's HYMPAVZI in hemophilia patients
-
326,126 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

